Dr. Teals

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the temporary relief of minor pain associated with simple backache, arthritis, muscle strains, muscle sprains, and bruises.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The recommended dosage for adults is 500 mg administered orally every 12 hours. For pediatric patients aged 6 to 12 years, the dosage is 250 mg taken orally every 12 hours. The maximum allowable dosage should not exceed 2000 mg per day.

This medication may be administered with or without food, providing flexibility in the timing of doses. In patients with renal impairment, it is essential to adjust the dosage based on individual creatinine clearance levels to ensure safety and efficacy.

Contraindications

Application is contraindicated on wounds or damaged, broken, or irritated skin due to the potential for exacerbating the condition and hindering proper healing.

Warnings and Precautions

The product is intended for external use only. It is imperative that healthcare professionals advise patients to use the product strictly as directed. Patients should be cautioned against bandaging the area tightly or using a heating pad in conjunction with the product, as this may lead to adverse effects.

Contact with the eyes or mucous membranes must be avoided to prevent irritation or injury. Additionally, the product should not be applied to wounds or any damaged, broken, or irritated skin, as this could exacerbate the condition or lead to further complications.

Healthcare professionals should instruct patients to discontinue use and seek medical advice if any of the following occur: the condition worsens, symptoms persist for more than seven days, symptoms resolve and then recur within a few days, redness appears, or irritation develops. Furthermore, it is advisable for patients who are pregnant or breastfeeding to consult a healthcare professional prior to using the product.

To ensure safety, the product should be kept out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center should be made without delay.

Side Effects

Patients should be aware that this product is for external use only. It is essential to use the product strictly as directed. Patients are advised against bandaging tightly or using it in conjunction with a heating pad, as these practices may lead to adverse effects. Additionally, contact with the eyes or mucous membranes should be avoided, and the product should not be applied to wounds or areas of damaged, broken, or irritated skin.

In clinical practice, patients are instructed to discontinue use and consult a healthcare professional if their condition worsens, if symptoms persist for more than seven days, or if symptoms resolve and then recur within a few days. The presence of redness or the development of irritation also warrants cessation of use and medical consultation.

Furthermore, it is recommended that patients who are pregnant or breastfeeding seek advice from a healthcare professional prior to using this product to ensure safety for both themselves and their child.

Drug Interactions

There are currently no specific drug interactions identified for the medication. Additionally, no interactions with laboratory tests have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary at this time. It is advisable for healthcare professionals to remain vigilant and consult updated resources as new data may emerge.

Packaging & NDC

Below are the non-prescription pack sizes of Dr. Teals (dr. teals muscle recovery pain relieving gel). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients 12 years of age or younger should consult a healthcare professional before use. It is essential to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data regarding the excretion of this medication in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

Additionally, it is recommended to consult local poison control centers or relevant toxicology resources for guidance on specific management protocols and antidotes, if applicable.

Documentation of the incident, including the amount and timing of the substance taken, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately.

Patients should be instructed not to apply the medication to wounds or any damaged, broken, or irritated skin. It is important for healthcare providers to inform patients to discontinue use and consult a doctor if any of the following occur: the condition worsens, symptoms persist for more than 7 days, symptoms clear up and then recur within a few days, redness appears, or irritation develops.

Additionally, healthcare providers should recommend that patients who are pregnant or breastfeeding consult a health professional before using the medication.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers, which should be referenced for accurate identification. It is essential to store the product at room temperature, ensuring that it is protected from light exposure to maintain its integrity. Freezing the product is strictly prohibited, as it may compromise its effectiveness. Additionally, once opened, the product must be discarded to ensure safety and efficacy.

Additional Clinical Information

The product is administered topically, with adults and children over 12 years advised to apply a generous amount of Dr Teals Muscle Recovery Gel to the affected area, massaging it in as needed, but not exceeding four applications per day. For children aged 12 years or younger, consultation with a doctor is recommended prior to use.

Clinicians should counsel patients to seek advice from a health professional if they are pregnant or breastfeeding. Additionally, it is important to keep the product out of reach of children; in the event of ingestion, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Dr. Teals, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)